A Randomised, Double-blind, Placebo-controlled Trial ofTrichuris suisova in Active Crohn’s disease-Reference-Cited by-同舟云学术

A Randomised, Double-blind, Placebo-controlled Trial ofTrichuris suisova in Active Crohn’s disease

Published:2016-10-05 Issue: Volume: Page:jjw184
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Schölmerich Jürgen,Fellermann Klaus,Seibold Frank W.,Rogler Gerhard,Langhorst Jost,Howaldt Stefanie,Novacek Gottfried,Petersen Andreas Munk,Bachmann Oliver,Matthes Harald,Hesselbarth Norbert,Teich Niels,Wehkamp Jan,Klaus Jochen,Ott Claudia,Dilger Karin,Greinwald Roland,Mueller Ralph,

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/11/4/390/17682379/jjw184.pdf

Reference38 articles.

1. New therapies for inflammatory bowel disease: from the bench to the bedside

2. Review: New Anti-Cytokines for IBD: What is in the Pipeline?

3. Helminth Infection Does Not Reduce Risk for Chronic Inflammatory Disease in a Population-Based Cohort Study

4. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions

5. The role of domestic hygiene in inflammatory bowel diseases: hepatitis A and worm infestations

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Immune Modulation by Gastrointestinal Nematodes;Annual Review of Immunology;2024-06-28

2. Probiotic Treatment of Ulcerative Colitis with Trichuris Suis Ova: A Randomised, Double-blinded, Placebo-controlled Clinical Trial [the PROCTO Trial];Journal of Crohn's and Colitis;2024-06-20

3. Colonic Tuft Cells: The Less-Recognized Therapeutic Targets in Inflammatory Bowel Disease and Colorectal Cancer;International Journal of Molecular Sciences;2024-06-05

4. Helminth-derived proteins as immune system regulators: a systematic review of their promise in alleviating colitis;BMC Immunology;2024-04-18

5. Helminths in alternative therapeutics of inflammatory bowel disease;Intestinal Research;2024-01-12